{"disease":{"id":"relapsed-or-refractory-b-cell-lymphomas","name":"relapsed or refractory b cell lymphomas"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03576807","title":"The Clinical Research of Anti-CD20 CAR-T Cells in Patients With Refractory or Relapsed B Lymphocyte Lymphoma","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Xin Wang","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}